MedGenome Secures $30 Million Series C Funding Led by Sequoia India and SofinaGenomics research and diagnostics company aims to accelerate biomarker discovery by leveraging the genetic diversity of the Indian population
FOSTER CITY, Calif., August 28, 2017-- MedGenome, a leading genomics research and diagnostics company, announced completion of $30 million in Series C financing led by Sequoia India and Sofina s.a., with participation by Zodius Capital; Kris Gopalakrishnan, co-founder and former CEO of Infosys; and Lakshmi Narayanan, former CEO of Cognizant.